CLINICAL RESPONSES OF SARILUMAB BASED ON RHEUMATOID FACTOR AND ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY STATUS IN PATIENTS WITH RHEUMATOID ARTHRITIS

被引：1
|
作者：
Emery, P. [1 ]
van Hoogstraten, H. [2 ]
Mangan, E. K. [3 ]
van Adelsberg, J. [3 ]
Fan, C. [2 ]
Kivitz, A. [4 ]
Pinheiro, G. da R. C. [5 ]
Huizinga, T. [6 ]
机构：
[1] Univ Leeds, Leeds, W Yorkshire, England
[2] Sanofi, Bridgewater, MA USA
[3] Regeneron Pharmaceut Inc, Tarrytown, NY USA
[4] Altoona Ctr Clin Res, Duncansville, PA USA
[5] Univ Estado Rio De Janeiro, Discipline Rheumatol, Rio De Janeiro, Brazil
[6] Leiden Univ, Med Ctr, Leiden, Netherlands
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2016年 / 75卷
关键词：
D O I：
10.1136/annrheumdis-2016-eular.4415
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
SAT0178
引用
收藏
页码：732 / 732
页数：1
相关论文
共 50 条
  • [31] Anti-cyclic citrullinated peptide antibodies in patients with rheumatoid arthritis and comorbidity
    Stamenkovic, Doris
    Stiglic-Rogoznica, Nives
    Stiglic, Mirna
    Avancini-Dobrovic, Viviana
    Grubisic-Karavanic, Vlasta
    Frlan-Vrgoe, Ljubinka
    Radovic, Endi
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2009, 27 (05) : 706 - 707
  • [32] Can Anti-Cyclic Citrullinated Peptide Antibody Negative Rheumatoid Arthritis Be Subdivided in Clinical Subphenotypes?
    de Rooy, Diederik P. C.
    Willemze, Annemiek
    Mertens, Bart
    Huizinga, Tom W. J.
    van der Helm-van Mil, Annette H. M.
    ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S135 - S135
  • [33] Methotrexate effect on anti-cyclic citrullinated peptide antibody levels in rheumatoid arthritis
    Spadaro, A
    Riccieri, V
    ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 (08) : 1241 - 1242
  • [34] Anti-cyclic citrullinated peptide antibody in rheumatoid arthritis: Relation with disease aggressiveness
    Del Val Del Amno, N.
    Bosch, R. Ibanez
    Manteca, C. Fito
    Polo, R. Gutierrez
    Cortina, E. Loza
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2006, 24 (03) : 281 - 286
  • [35] Clinical significance of anti-cyclic citrullinated peptide antibodies in patients with juvenile rheumatoid arthritis
    Li Bo
    Ye Zhizho
    Guo Fenlia
    Li Jianso
    Pediatric Rheumatology, 6 (Suppl 1)
  • [36] Diagnostic and clinical value of anti-cyclic citrullinated peptide antibodies compared with rheumatoid factor isotypes in rheumatoid arthritis
    Vallbracht, I
    Rieber, J
    Oppermann, M
    Förger, F
    Siebert, U
    Helmke, K
    ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 (09) : 1079 - 1084
  • [37] A comparative evaluation of the diagnostic value of anti-cyclic citrullinated peptide and rheumatoid factor in rheumatoid arthritis
    Cho, Sun Young
    Kang, So Young
    Lee, Hee Joo
    Lee, Woo In
    KOREAN JOURNAL OF LABORATORY MEDICINE, 2008, 28 (01): : 39 - 45
  • [38] Rheumatoid factor, but not anti-cyclic citrullinated peptide antibodies, is modulated by infliximab treatment in rheumatoid arthritis
    De Rycke, L
    Verhelst, X
    Kruithof, E
    Van den Bosch, F
    Hoffman, IEA
    Veys, EM
    De Keyser, F
    ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 (02) : 299 - 302
  • [39] Diagnostic Value of Combined Test of Anti-Cyclic Citrullinated Peptide Antibody, AKA Antibody, Carp Antibody, and Rheumatoid Factor for Rheumatoid Arthritis
    Zhou, Qiongsong
    Li, Na
    Hu, Jing
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2025, 28 (01)
  • [40] Rate of Anti-Cyclic Citrullinated Peptide Antibody and Rheumatoid Factor Seroconversion in Patients with Undifferentiated Arthritis or Early Rheumatoid Arthritis Treated with Abatacept.
    Huizinga, Tom W. J.
    Emery, Paul
    Westhovens, Rene
    Le Bars, Manuela
    Gaillez, Corine
    Poncet, Coralie
    Elegbe, Ayanbola
    Smolen, Josef S.
    ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S872 - S873
12345